Author Question: Which of the following is true regarding the participant-variable design? a. The independent ... (Read 110 times)

Pineapplelove6

  • Hero Member
  • *****
  • Posts: 560
Which of the following is true regarding the participant-variable design?
 
  a. The independent variables used in the design are always demographic variables.
  b. The independent variables always involve pre-existing personality characteristics of the participants.
  c. Because the participant variable is measured, causal conclusions about the effect of the participant variable on the dependent variable are difficult to draw.
  d. Because the participant variable can be manipulated, causal conclusions can frequently be made.

Question 2

A study that assesses how a patient with a leg fracture responds to a new physical therapy program is an example of a
 
  a. participant-variable design.
  b. time-series design.
  c. single-participant design.
  d. cross-sectional design.



Carliemb17

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

c

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library